Video

Dr. Dunavin on Ongoing Research for Myelofibrosis Treatments

Neil Dunavin, MD, MS, discusses ongoing research on therapies for patients with myelofibrosis.

Neil Dunavin, MD, MS, assistant professor of medicine, School of Medicine, University of California, San Francisco (UCSF), UCSF Helen Diller Family Comprehensive Cancer Center, discusses ongoing research on therapies for patients with myelofibrosis.

At the 2019 ASH Annual Meeting, novel combination therapies with ruxolitinib (Jakafi) generated excitement, says Dunavin, who hopes that these combinations move on to later-phase studies. However, no large, practice-changing phase III studies in myelofibrosis were presented at the meeting, according to Dunavin.

Luspatercept-aamt (Reblozyl), a red blood cell stimulatory agent, is approved for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions, based on data from the BELIEVE trial (NCT02604433). Results from the trial showed that treatment with luspatercept-aamt resulted in significant reductions in red blood cell transfusion burden in this patient population.

In the future, the agent might also receive approval for use in patients with myelodysplastic syndrome with ring sideroblasts who need more red blood cells, says Dunavin. The drug is given to patients with isolated anemia, which is a significant problem in patients with myelofibrosis. As such, Dunavin is interested to see whether luspatercept-aamt can be given to patients with myelofibrosis as well.

Related Videos
Timothy Gershon, MD, PhD
Jordan Hansford, MD
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD